Quantitative Changes of Melanoma-Associated Antigens as a Biomarker for Targeted Therapy Response

Experimental Dermatology - United Kingdom
doi 10.1111/exd.12947
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

High Molecular Weight-Melanoma-Associated Antigen as a Biomarker of Desmoplastic Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2009English

Mitochondria-Targeted Therapy for Metastatic Melanoma

English

Phenotypic Heterogeneity and Evolution of Melanoma Cells Associated With Targeted Therapy Resistance

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2019English

Circulating Melanoma Cells as a Predictive Biomarker

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2013English

Rechallenge of Targeted Therapy in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2019English

Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series

British Journal of Cancer
Cancer ResearchOncology
2016English

Combining Immunotherapy With Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

Frontiers in Immunology
AllergyImmunology
2015English

Arginine Deprivation as a Targeted Therapy for Cancer

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2008English

Adoptive T-Cell Transfer Therapy and Oncogene-Targeted Therapy for Melanoma: The Search for Synergy

Clinical Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy